nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2E1—Fingolimod—multiple sclerosis	0.159	0.246	CbGbCtD
Trabectedin—CYP2D6—Fingolimod—multiple sclerosis	0.076	0.117	CbGbCtD
Trabectedin—CYP2E1—Mitoxantrone—multiple sclerosis	0.075	0.116	CbGbCtD
Trabectedin—CYP3A4—Fingolimod—multiple sclerosis	0.0483	0.0746	CbGbCtD
Trabectedin—CYP2C19—Prednisone—multiple sclerosis	0.039	0.0602	CbGbCtD
Trabectedin—CYP2E1—Dexamethasone—multiple sclerosis	0.0389	0.06	CbGbCtD
Trabectedin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0311	0.048	CbGbCtD
Trabectedin—CYP2C19—Dexamethasone—multiple sclerosis	0.0244	0.0376	CbGbCtD
Trabectedin—CYP3A4—Triamcinolone—multiple sclerosis	0.0236	0.0364	CbGbCtD
Trabectedin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0227	0.0351	CbGbCtD
Trabectedin—CYP2C9—Dexamethasone—multiple sclerosis	0.0203	0.0313	CbGbCtD
Trabectedin—CYP3A4—Betamethasone—multiple sclerosis	0.0202	0.0312	CbGbCtD
Trabectedin—CYP3A4—Prednisolone—multiple sclerosis	0.02	0.0308	CbGbCtD
Trabectedin—CYP3A4—Prednisone—multiple sclerosis	0.0189	0.0291	CbGbCtD
Trabectedin—CYP2D6—Dexamethasone—multiple sclerosis	0.0185	0.0286	CbGbCtD
Trabectedin—CYP3A4—Dexamethasone—multiple sclerosis	0.0118	0.0182	CbGbCtD
Trabectedin—Haemoglobin—Betamethasone—multiple sclerosis	0.000369	0.00155	CcSEcCtD
Trabectedin—Vomiting—Cladribine—multiple sclerosis	0.000368	0.00155	CcSEcCtD
Trabectedin—Haemorrhage—Betamethasone—multiple sclerosis	0.000367	0.00155	CcSEcCtD
Trabectedin—Haemorrhage—Dexamethasone—multiple sclerosis	0.000367	0.00155	CcSEcCtD
Trabectedin—Angiopathy—Methylprednisolone—multiple sclerosis	0.000366	0.00154	CcSEcCtD
Trabectedin—Rash—Cladribine—multiple sclerosis	0.000365	0.00154	CcSEcCtD
Trabectedin—Dermatitis—Cladribine—multiple sclerosis	0.000365	0.00154	CcSEcCtD
Trabectedin—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000364	0.00153	CcSEcCtD
Trabectedin—Anorexia—Mitoxantrone—multiple sclerosis	0.000363	0.00153	CcSEcCtD
Trabectedin—Headache—Cladribine—multiple sclerosis	0.000363	0.00153	CcSEcCtD
Trabectedin—Weight decreased—Prednisone—multiple sclerosis	0.000361	0.00152	CcSEcCtD
Trabectedin—Hypotension—Mitoxantrone—multiple sclerosis	0.000356	0.0015	CcSEcCtD
Trabectedin—Mental disorder—Methylprednisolone—multiple sclerosis	0.000354	0.00149	CcSEcCtD
Trabectedin—Malnutrition—Methylprednisolone—multiple sclerosis	0.000351	0.00148	CcSEcCtD
Trabectedin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000347	0.00146	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000347	0.00146	CcSEcCtD
Trabectedin—Dysgeusia—Triamcinolone—multiple sclerosis	0.000345	0.00145	CcSEcCtD
Trabectedin—Nausea—Cladribine—multiple sclerosis	0.000344	0.00145	CcSEcCtD
Trabectedin—Syncope—Prednisolone—multiple sclerosis	0.000343	0.00145	CcSEcCtD
Trabectedin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000342	0.00144	CcSEcCtD
Trabectedin—Back pain—Triamcinolone—multiple sclerosis	0.000341	0.00143	CcSEcCtD
Trabectedin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00034	0.00143	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisolone—multiple sclerosis	0.000336	0.00142	CcSEcCtD
Trabectedin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000335	0.00141	CcSEcCtD
Trabectedin—Angiopathy—Dexamethasone—multiple sclerosis	0.000333	0.0014	CcSEcCtD
Trabectedin—Angiopathy—Betamethasone—multiple sclerosis	0.000333	0.0014	CcSEcCtD
Trabectedin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000331	0.00139	CcSEcCtD
Trabectedin—Fatigue—Mitoxantrone—multiple sclerosis	0.000328	0.00138	CcSEcCtD
Trabectedin—Constipation—Mitoxantrone—multiple sclerosis	0.000326	0.00137	CcSEcCtD
Trabectedin—Alopecia—Dexamethasone—multiple sclerosis	0.000324	0.00137	CcSEcCtD
Trabectedin—Alopecia—Betamethasone—multiple sclerosis	0.000324	0.00137	CcSEcCtD
Trabectedin—Diarrhoea—Azathioprine—multiple sclerosis	0.000322	0.00136	CcSEcCtD
Trabectedin—Haemoglobin—Prednisone—multiple sclerosis	0.000321	0.00135	CcSEcCtD
Trabectedin—Haemorrhage—Prednisone—multiple sclerosis	0.00032	0.00135	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—multiple sclerosis	0.000317	0.00133	CcSEcCtD
Trabectedin—Syncope—Triamcinolone—multiple sclerosis	0.000316	0.00133	CcSEcCtD
Trabectedin—Syncope—Methylprednisolone—multiple sclerosis	0.000315	0.00133	CcSEcCtD
Trabectedin—Connective tissue disorder—Prednisone—multiple sclerosis	0.000314	0.00132	CcSEcCtD
Trabectedin—Oedema—Prednisolone—multiple sclerosis	0.000312	0.00132	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—multiple sclerosis	0.000312	0.00131	CcSEcCtD
Trabectedin—Dizziness—Azathioprine—multiple sclerosis	0.000312	0.00131	CcSEcCtD
Trabectedin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000311	0.00131	CcSEcCtD
Trabectedin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000309	0.0013	CcSEcCtD
Trabectedin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000309	0.0013	CcSEcCtD
Trabectedin—Shock—Prednisolone—multiple sclerosis	0.000307	0.00129	CcSEcCtD
Trabectedin—Cough—Triamcinolone—multiple sclerosis	0.000307	0.00129	CcSEcCtD
Trabectedin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000301	0.00127	CcSEcCtD
Trabectedin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000301	0.00127	CcSEcCtD
Trabectedin—Myalgia—Triamcinolone—multiple sclerosis	0.0003	0.00126	CcSEcCtD
Trabectedin—Vomiting—Azathioprine—multiple sclerosis	0.0003	0.00126	CcSEcCtD
Trabectedin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000299	0.00126	CcSEcCtD
Trabectedin—Myalgia—Methylprednisolone—multiple sclerosis	0.000299	0.00126	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Infestation—Methotrexate—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Rash—Azathioprine—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Dermatitis—Azathioprine—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Flushing—Prednisone—multiple sclerosis	0.000297	0.00125	CcSEcCtD
Trabectedin—Headache—Azathioprine—multiple sclerosis	0.000295	0.00124	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—multiple sclerosis	0.00029	0.00122	CcSEcCtD
Trabectedin—Angiopathy—Prednisone—multiple sclerosis	0.00029	0.00122	CcSEcCtD
Trabectedin—Oedema—Triamcinolone—multiple sclerosis	0.000287	0.00121	CcSEcCtD
Trabectedin—Syncope—Dexamethasone—multiple sclerosis	0.000286	0.00121	CcSEcCtD
Trabectedin—Syncope—Betamethasone—multiple sclerosis	0.000286	0.00121	CcSEcCtD
Trabectedin—Infection—Triamcinolone—multiple sclerosis	0.000285	0.0012	CcSEcCtD
Trabectedin—Infection—Methylprednisolone—multiple sclerosis	0.000285	0.0012	CcSEcCtD
Trabectedin—Shock—Triamcinolone—multiple sclerosis	0.000283	0.00119	CcSEcCtD
Trabectedin—Insomnia—Prednisolone—multiple sclerosis	0.000283	0.00119	CcSEcCtD
Trabectedin—Alopecia—Prednisone—multiple sclerosis	0.000282	0.00119	CcSEcCtD
Trabectedin—Shock—Methylprednisolone—multiple sclerosis	0.000282	0.00119	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000281	0.00119	CcSEcCtD
Trabectedin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000281	0.00118	CcSEcCtD
Trabectedin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000281	0.00118	CcSEcCtD
Trabectedin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000281	0.00118	CcSEcCtD
Trabectedin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000281	0.00118	CcSEcCtD
Trabectedin—Paraesthesia—Prednisolone—multiple sclerosis	0.000281	0.00118	CcSEcCtD
Trabectedin—Mental disorder—Prednisone—multiple sclerosis	0.00028	0.00118	CcSEcCtD
Trabectedin—Nausea—Azathioprine—multiple sclerosis	0.00028	0.00118	CcSEcCtD
Trabectedin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000278	0.00117	CcSEcCtD
Trabectedin—Malnutrition—Prednisone—multiple sclerosis	0.000278	0.00117	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000278	0.00117	CcSEcCtD
Trabectedin—Asthenia—Mitoxantrone—multiple sclerosis	0.000273	0.00115	CcSEcCtD
Trabectedin—Myalgia—Betamethasone—multiple sclerosis	0.000272	0.00115	CcSEcCtD
Trabectedin—Myalgia—Dexamethasone—multiple sclerosis	0.000272	0.00115	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—multiple sclerosis	0.000268	0.00113	CcSEcCtD
Trabectedin—Hypotension—Methylprednisolone—multiple sclerosis	0.000268	0.00113	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—multiple sclerosis	0.000267	0.00113	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000262	0.0011	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000261	0.0011	CcSEcCtD
Trabectedin—Oedema—Dexamethasone—multiple sclerosis	0.000261	0.0011	CcSEcCtD
Trabectedin—Oedema—Betamethasone—multiple sclerosis	0.000261	0.0011	CcSEcCtD
Trabectedin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000261	0.0011	CcSEcCtD
Trabectedin—Insomnia—Triamcinolone—multiple sclerosis	0.00026	0.00109	CcSEcCtD
Trabectedin—Insomnia—Methylprednisolone—multiple sclerosis	0.000259	0.00109	CcSEcCtD
Trabectedin—Infection—Dexamethasone—multiple sclerosis	0.000259	0.00109	CcSEcCtD
Trabectedin—Infection—Betamethasone—multiple sclerosis	0.000259	0.00109	CcSEcCtD
Trabectedin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000258	0.00109	CcSEcCtD
Trabectedin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000257	0.00108	CcSEcCtD
Trabectedin—Anaemia—Prednisone—multiple sclerosis	0.000257	0.00108	CcSEcCtD
Trabectedin—Shock—Dexamethasone—multiple sclerosis	0.000256	0.00108	CcSEcCtD
Trabectedin—Shock—Betamethasone—multiple sclerosis	0.000256	0.00108	CcSEcCtD
Trabectedin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000256	0.00108	CcSEcCtD
Trabectedin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000256	0.00108	CcSEcCtD
Trabectedin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000256	0.00108	CcSEcCtD
Trabectedin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000255	0.00108	CcSEcCtD
Trabectedin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000255	0.00108	CcSEcCtD
Trabectedin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000253	0.00107	CcSEcCtD
Trabectedin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000252	0.00106	CcSEcCtD
Trabectedin—Syncope—Prednisone—multiple sclerosis	0.000249	0.00105	CcSEcCtD
Trabectedin—Anorexia—Betamethasone—multiple sclerosis	0.000248	0.00105	CcSEcCtD
Trabectedin—Anorexia—Dexamethasone—multiple sclerosis	0.000248	0.00105	CcSEcCtD
Trabectedin—Fatigue—Triamcinolone—multiple sclerosis	0.000248	0.00104	CcSEcCtD
Trabectedin—Fatigue—Methylprednisolone—multiple sclerosis	0.000247	0.00104	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisone—multiple sclerosis	0.000244	0.00103	CcSEcCtD
Trabectedin—Hypotension—Betamethasone—multiple sclerosis	0.000244	0.00103	CcSEcCtD
Trabectedin—Hypotension—Dexamethasone—multiple sclerosis	0.000244	0.00103	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—multiple sclerosis	0.000242	0.00102	CcSEcCtD
Trabectedin—Vomiting—Mitoxantrone—multiple sclerosis	0.000242	0.00102	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000241	0.00101	CcSEcCtD
Trabectedin—Rash—Mitoxantrone—multiple sclerosis	0.00024	0.00101	CcSEcCtD
Trabectedin—Dermatitis—Mitoxantrone—multiple sclerosis	0.00024	0.00101	CcSEcCtD
Trabectedin—Headache—Mitoxantrone—multiple sclerosis	0.000239	0.001	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000238	0.001	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000238	0.001	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—multiple sclerosis	0.000237	0.000998	CcSEcCtD
Trabectedin—Myalgia—Prednisone—multiple sclerosis	0.000237	0.000998	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—multiple sclerosis	0.000236	0.000994	CcSEcCtD
Trabectedin—Insomnia—Dexamethasone—multiple sclerosis	0.000236	0.000993	CcSEcCtD
Trabectedin—Insomnia—Betamethasone—multiple sclerosis	0.000236	0.000993	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000235	0.000991	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000234	0.000987	CcSEcCtD
Trabectedin—Paraesthesia—Betamethasone—multiple sclerosis	0.000234	0.000986	CcSEcCtD
Trabectedin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000234	0.000986	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—multiple sclerosis	0.000234	0.000986	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—multiple sclerosis	0.000232	0.000979	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisolone—multiple sclerosis	0.00023	0.00097	CcSEcCtD
Trabectedin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000229	0.000967	CcSEcCtD
Trabectedin—Dyspepsia—Betamethasone—multiple sclerosis	0.000229	0.000967	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—multiple sclerosis	0.000228	0.000959	CcSEcCtD
Trabectedin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000227	0.000957	CcSEcCtD
Trabectedin—Oedema—Prednisone—multiple sclerosis	0.000227	0.000956	CcSEcCtD
Trabectedin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000227	0.000955	CcSEcCtD
Trabectedin—Decreased appetite—Betamethasone—multiple sclerosis	0.000227	0.000955	CcSEcCtD
Trabectedin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000227	0.000955	CcSEcCtD
Trabectedin—Nausea—Mitoxantrone—multiple sclerosis	0.000226	0.000953	CcSEcCtD
Trabectedin—Infection—Prednisone—multiple sclerosis	0.000226	0.00095	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000225	0.000948	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000225	0.000948	CcSEcCtD
Trabectedin—Back pain—Methotrexate—multiple sclerosis	0.000225	0.000947	CcSEcCtD
Trabectedin—Fatigue—Dexamethasone—multiple sclerosis	0.000225	0.000947	CcSEcCtD
Trabectedin—Fatigue—Betamethasone—multiple sclerosis	0.000225	0.000947	CcSEcCtD
Trabectedin—Shock—Prednisone—multiple sclerosis	0.000223	0.000941	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—multiple sclerosis	0.000223	0.000938	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—multiple sclerosis	0.000221	0.000929	CcSEcCtD
Trabectedin—Anorexia—Prednisone—multiple sclerosis	0.000216	0.000912	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—multiple sclerosis	0.000215	0.000905	CcSEcCtD
Trabectedin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000213	0.000898	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000213	0.000898	CcSEcCtD
Trabectedin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000212	0.000892	CcSEcCtD
Trabectedin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000211	0.00089	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—multiple sclerosis	0.000208	0.000877	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000207	0.000871	CcSEcCtD
Trabectedin—Dizziness—Prednisolone—multiple sclerosis	0.000207	0.00087	CcSEcCtD
Trabectedin—Asthenia—Triamcinolone—multiple sclerosis	0.000206	0.000868	CcSEcCtD
Trabectedin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000206	0.000868	CcSEcCtD
Trabectedin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000206	0.000868	CcSEcCtD
Trabectedin—Abdominal pain—Betamethasone—multiple sclerosis	0.000206	0.000868	CcSEcCtD
Trabectedin—Body temperature increased—Betamethasone—multiple sclerosis	0.000206	0.000868	CcSEcCtD
Trabectedin—Asthenia—Methylprednisolone—multiple sclerosis	0.000206	0.000866	CcSEcCtD
Trabectedin—Insomnia—Prednisone—multiple sclerosis	0.000205	0.000865	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—multiple sclerosis	0.000204	0.000859	CcSEcCtD
Trabectedin—Cough—Methotrexate—multiple sclerosis	0.000203	0.000855	CcSEcCtD
Trabectedin—Dyspepsia—Prednisone—multiple sclerosis	0.0002	0.000842	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—multiple sclerosis	0.000198	0.000834	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—multiple sclerosis	0.000198	0.000834	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—multiple sclerosis	0.000197	0.000831	CcSEcCtD
Trabectedin—Rash—Prednisolone—multiple sclerosis	0.000197	0.00083	CcSEcCtD
Trabectedin—Dermatitis—Prednisolone—multiple sclerosis	0.000197	0.000829	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000197	0.000828	CcSEcCtD
Trabectedin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000196	0.000826	CcSEcCtD
Trabectedin—Fatigue—Prednisone—multiple sclerosis	0.000196	0.000825	CcSEcCtD
Trabectedin—Headache—Prednisolone—multiple sclerosis	0.000196	0.000824	CcSEcCtD
Trabectedin—Constipation—Prednisone—multiple sclerosis	0.000194	0.000818	CcSEcCtD
Trabectedin—Dizziness—Triamcinolone—multiple sclerosis	0.00019	0.0008	CcSEcCtD
Trabectedin—Dizziness—Methylprednisolone—multiple sclerosis	0.00019	0.000799	CcSEcCtD
Trabectedin—Infection—Methotrexate—multiple sclerosis	0.000188	0.000794	CcSEcCtD
Trabectedin—Asthenia—Betamethasone—multiple sclerosis	0.000187	0.000788	CcSEcCtD
Trabectedin—Asthenia—Dexamethasone—multiple sclerosis	0.000187	0.000788	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000186	0.000784	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000186	0.000783	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000186	0.000782	CcSEcCtD
Trabectedin—Nausea—Prednisolone—multiple sclerosis	0.000186	0.000782	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—multiple sclerosis	0.000184	0.000776	CcSEcCtD
Trabectedin—Vomiting—Triamcinolone—multiple sclerosis	0.000183	0.00077	CcSEcCtD
Trabectedin—Vomiting—Methylprednisolone—multiple sclerosis	0.000182	0.000768	CcSEcCtD
Trabectedin—Rash—Triamcinolone—multiple sclerosis	0.000181	0.000763	CcSEcCtD
Trabectedin—Dermatitis—Triamcinolone—multiple sclerosis	0.000181	0.000762	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—multiple sclerosis	0.000181	0.000762	CcSEcCtD
Trabectedin—Rash—Methylprednisolone—multiple sclerosis	0.000181	0.000761	CcSEcCtD
Trabectedin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000181	0.000761	CcSEcCtD
Trabectedin—Headache—Triamcinolone—multiple sclerosis	0.00018	0.000758	CcSEcCtD
Trabectedin—Headache—Methylprednisolone—multiple sclerosis	0.00018	0.000757	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—multiple sclerosis	0.000179	0.000756	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—multiple sclerosis	0.000179	0.000756	CcSEcCtD
Trabectedin—Diarrhoea—Betamethasone—multiple sclerosis	0.000178	0.000751	CcSEcCtD
Trabectedin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000178	0.000751	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—multiple sclerosis	0.000177	0.000747	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000173	0.000728	CcSEcCtD
Trabectedin—Dizziness—Betamethasone—multiple sclerosis	0.000172	0.000726	CcSEcCtD
Trabectedin—Dizziness—Dexamethasone—multiple sclerosis	0.000172	0.000726	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—multiple sclerosis	0.000172	0.000723	CcSEcCtD
Trabectedin—Nausea—Triamcinolone—multiple sclerosis	0.000171	0.000719	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—multiple sclerosis	0.00017	0.000718	CcSEcCtD
Trabectedin—Nausea—Methylprednisolone—multiple sclerosis	0.00017	0.000717	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—multiple sclerosis	0.000169	0.000713	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—multiple sclerosis	0.000167	0.000705	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—multiple sclerosis	0.000167	0.000704	CcSEcCtD
Trabectedin—Vomiting—Dexamethasone—multiple sclerosis	0.000166	0.000698	CcSEcCtD
Trabectedin—Vomiting—Betamethasone—multiple sclerosis	0.000166	0.000698	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—multiple sclerosis	0.000165	0.000695	CcSEcCtD
Trabectedin—Rash—Dexamethasone—multiple sclerosis	0.000164	0.000692	CcSEcCtD
Trabectedin—Rash—Betamethasone—multiple sclerosis	0.000164	0.000692	CcSEcCtD
Trabectedin—Dermatitis—Dexamethasone—multiple sclerosis	0.000164	0.000692	CcSEcCtD
Trabectedin—Dermatitis—Betamethasone—multiple sclerosis	0.000164	0.000692	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000164	0.00069	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—multiple sclerosis	0.000164	0.000689	CcSEcCtD
Trabectedin—Headache—Betamethasone—multiple sclerosis	0.000163	0.000688	CcSEcCtD
Trabectedin—Headache—Dexamethasone—multiple sclerosis	0.000163	0.000688	CcSEcCtD
Trabectedin—Asthenia—Prednisone—multiple sclerosis	0.000163	0.000686	CcSEcCtD
Trabectedin—Diarrhoea—Prednisone—multiple sclerosis	0.000155	0.000654	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000155	0.000654	CcSEcCtD
Trabectedin—Nausea—Dexamethasone—multiple sclerosis	0.000155	0.000652	CcSEcCtD
Trabectedin—Nausea—Betamethasone—multiple sclerosis	0.000155	0.000652	CcSEcCtD
Trabectedin—Dizziness—Prednisone—multiple sclerosis	0.00015	0.000632	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—multiple sclerosis	0.00015	0.000632	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—multiple sclerosis	0.00015	0.000632	CcSEcCtD
Trabectedin—Vomiting—Prednisone—multiple sclerosis	0.000144	0.000608	CcSEcCtD
Trabectedin—Rash—Prednisone—multiple sclerosis	0.000143	0.000603	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—multiple sclerosis	0.000143	0.000602	CcSEcCtD
Trabectedin—Headache—Prednisone—multiple sclerosis	0.000142	0.000599	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—multiple sclerosis	0.00014	0.000589	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—multiple sclerosis	0.000136	0.000573	CcSEcCtD
Trabectedin—Nausea—Prednisone—multiple sclerosis	0.000135	0.000568	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—multiple sclerosis	0.00013	0.000547	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—multiple sclerosis	0.000125	0.000529	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—multiple sclerosis	0.000121	0.000508	CcSEcCtD
Trabectedin—Rash—Methotrexate—multiple sclerosis	0.00012	0.000504	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—multiple sclerosis	0.00012	0.000503	CcSEcCtD
Trabectedin—Headache—Methotrexate—multiple sclerosis	0.000119	0.000501	CcSEcCtD
Trabectedin—Nausea—Methotrexate—multiple sclerosis	0.000113	0.000475	CcSEcCtD
Trabectedin—SRC—Signaling by VEGF—MAPK1—multiple sclerosis	7.52e-05	0.000657	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ITGA4—multiple sclerosis	7.51e-05	0.000656	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IFNB1—multiple sclerosis	7.45e-05	0.000651	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—TYK2—multiple sclerosis	7.41e-05	0.000648	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD28—multiple sclerosis	7.4e-05	0.000647	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CCR2—multiple sclerosis	7.27e-05	0.000635	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—MYC—multiple sclerosis	7.19e-05	0.000628	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	7.19e-05	0.000628	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD28—multiple sclerosis	7.11e-05	0.000621	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GPC5—multiple sclerosis	7.05e-05	0.000616	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	7.04e-05	0.000615	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—STAT3—multiple sclerosis	7.03e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTPRC—multiple sclerosis	6.98e-05	0.00061	CbGpPWpGaD
Trabectedin—SRC—Immune System—CBLB—multiple sclerosis	6.96e-05	0.000608	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—STAT3—multiple sclerosis	6.91e-05	0.000604	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—MYC—multiple sclerosis	6.89e-05	0.000602	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TGFB1—multiple sclerosis	6.87e-05	0.0006	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CD80—multiple sclerosis	6.75e-05	0.00059	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DPB1—multiple sclerosis	6.75e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—MAPK1—multiple sclerosis	6.74e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IFNB1—multiple sclerosis	6.71e-05	0.000586	CbGpPWpGaD
Trabectedin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.61e-05	0.000578	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TAGAP—multiple sclerosis	6.59e-05	0.000576	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD40—multiple sclerosis	6.49e-05	0.000567	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ITGA4—multiple sclerosis	6.49e-05	0.000567	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CTLA4—multiple sclerosis	6.4e-05	0.000559	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MAPK1—multiple sclerosis	6.39e-05	0.000558	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—STAT3—multiple sclerosis	6.32e-05	0.000552	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SRM—multiple sclerosis	6.31e-05	0.000551	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—STAT3—multiple sclerosis	6.29e-05	0.00055	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—MAPK1—multiple sclerosis	6.28e-05	0.000549	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	6.22e-05	0.000543	CbGpPWpGaD
Trabectedin—SRC—Immune System—MX1—multiple sclerosis	6.18e-05	0.00054	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	6.12e-05	0.000535	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DRA—multiple sclerosis	5.98e-05	0.000522	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—STAT3—multiple sclerosis	5.86e-05	0.000512	CbGpPWpGaD
Trabectedin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.84e-05	0.00051	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—RRM1—multiple sclerosis	5.84e-05	0.00051	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.83e-05	0.000509	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SRM—multiple sclerosis	5.8e-05	0.000507	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—IL6—multiple sclerosis	5.78e-05	0.000505	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—S1PR1—multiple sclerosis	5.76e-05	0.000503	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	5.76e-05	0.000503	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	5.76e-05	0.000503	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SRM—multiple sclerosis	5.75e-05	0.000502	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—MAPK1—multiple sclerosis	5.75e-05	0.000502	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—STAT3—multiple sclerosis	5.73e-05	0.000501	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—MAPK1—multiple sclerosis	5.72e-05	0.0005	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	5.72e-05	0.0005	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—TYK2—multiple sclerosis	5.7e-05	0.000498	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—MAPK1—multiple sclerosis	5.69e-05	0.000497	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—VCAM1—multiple sclerosis	5.64e-05	0.000493	CbGpPWpGaD
Trabectedin—SRC—Immune System—NOD1—multiple sclerosis	5.64e-05	0.000492	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DQA1—multiple sclerosis	5.63e-05	0.000492	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GPC5—multiple sclerosis	5.6e-05	0.00049	CbGpPWpGaD
Trabectedin—SRC—Immune System—MALT1—multiple sclerosis	5.44e-05	0.000476	CbGpPWpGaD
Trabectedin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.37e-05	0.00047	CbGpPWpGaD
Trabectedin—SRC—Immune System—IRF5—multiple sclerosis	5.36e-05	0.000468	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—MAPK1—multiple sclerosis	5.33e-05	0.000465	CbGpPWpGaD
Trabectedin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.33e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD86—multiple sclerosis	5.28e-05	0.000461	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MAPK1—multiple sclerosis	5.28e-05	0.000461	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DQB1—multiple sclerosis	5.27e-05	0.00046	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GPC5—multiple sclerosis	5.27e-05	0.00046	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	5.23e-05	0.000457	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MAPK1—multiple sclerosis	5.21e-05	0.000455	CbGpPWpGaD
Trabectedin—SRC—Disease—RPL5—multiple sclerosis	5.2e-05	0.000455	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	5.19e-05	0.000454	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—TYK2—multiple sclerosis	5.16e-05	0.000451	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2RA—multiple sclerosis	5.13e-05	0.000448	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.12e-05	0.000448	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFIH1—multiple sclerosis	5.12e-05	0.000447	CbGpPWpGaD
Trabectedin—SRC—Immune System—IRF8—multiple sclerosis	5.12e-05	0.000447	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-G—multiple sclerosis	5.12e-05	0.000447	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.11e-05	0.000447	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD86—multiple sclerosis	5.07e-05	0.000443	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—MAPK1—multiple sclerosis	5.03e-05	0.00044	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.01e-05	0.000438	CbGpPWpGaD
Trabectedin—SRC—Disease—SLC11A1—multiple sclerosis	4.98e-05	0.000435	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD40LG—multiple sclerosis	4.97e-05	0.000434	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HLA-B—multiple sclerosis	4.93e-05	0.00043	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD8A—multiple sclerosis	4.92e-05	0.00043	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—IL6—multiple sclerosis	4.91e-05	0.000429	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RGS1—multiple sclerosis	4.9e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Immune System—TNFAIP3—multiple sclerosis	4.79e-05	0.000419	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.77e-05	0.000417	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-B—multiple sclerosis	4.73e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	4.72e-05	0.000412	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GPR65—multiple sclerosis	4.64e-05	0.000406	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.55e-05	0.000397	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.53e-05	0.000396	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.46e-05	0.00039	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.44e-05	0.000388	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.44e-05	0.000388	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—IL6—multiple sclerosis	4.42e-05	0.000386	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—IL6—multiple sclerosis	4.39e-05	0.000384	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-A—multiple sclerosis	4.38e-05	0.000383	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—IL6—multiple sclerosis	4.37e-05	0.000382	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.36e-05	0.000381	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.34e-05	0.000379	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD28—multiple sclerosis	4.31e-05	0.000377	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCR1—multiple sclerosis	4.25e-05	0.000371	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL13—multiple sclerosis	4.25e-05	0.000371	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTPRC—multiple sclerosis	4.23e-05	0.00037	CbGpPWpGaD
Trabectedin—SRC—Immune System—CCR2—multiple sclerosis	4.23e-05	0.00037	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TLR4—multiple sclerosis	4.17e-05	0.000365	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—IL6—multiple sclerosis	4.09e-05	0.000358	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DPB1—multiple sclerosis	4.09e-05	0.000357	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.09e-05	0.000357	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.09e-05	0.000357	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP9—multiple sclerosis	4.06e-05	0.000355	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.06e-05	0.000355	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—IL6—multiple sclerosis	4.06e-05	0.000354	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4.05e-05	0.000354	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4.05e-05	0.000354	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—IL6—multiple sclerosis	4.02e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DRB1—multiple sclerosis	4e-05	0.00035	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—IL6—multiple sclerosis	4e-05	0.00035	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—STAT3—multiple sclerosis	3.99e-05	0.000349	CbGpPWpGaD
Trabectedin—SRC—Disease—CD28—multiple sclerosis	3.98e-05	0.000348	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.96e-05	0.000346	CbGpPWpGaD
Trabectedin—SRC—Immune System—ITGA4—multiple sclerosis	3.94e-05	0.000344	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD40—multiple sclerosis	3.94e-05	0.000344	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNB1—multiple sclerosis	3.91e-05	0.000341	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.89e-05	0.00034	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTLA4—multiple sclerosis	3.88e-05	0.000339	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD80—multiple sclerosis	3.85e-05	0.000337	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ICAM1—multiple sclerosis	3.84e-05	0.000336	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SRM—multiple sclerosis	3.79e-05	0.000331	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.74e-05	0.000326	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ALB—multiple sclerosis	3.71e-05	0.000324	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.7e-05	0.000324	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD80—multiple sclerosis	3.7e-05	0.000323	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TYK2—multiple sclerosis	3.68e-05	0.000322	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MAPK1—multiple sclerosis	3.63e-05	0.000317	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	3.63e-05	0.000317	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.55e-05	0.00031	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.51e-05	0.000307	CbGpPWpGaD
Trabectedin—SRC—Immune System—VCAM1—multiple sclerosis	3.42e-05	0.000299	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DQA1—multiple sclerosis	3.41e-05	0.000298	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.37e-05	0.000294	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—BCHE—multiple sclerosis	3.35e-05	0.000293	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MAPK1—multiple sclerosis	3.28e-05	0.000287	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TYK2—multiple sclerosis	3.25e-05	0.000284	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DQB1—multiple sclerosis	3.19e-05	0.000279	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.1e-05	0.000271	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD86—multiple sclerosis	3.08e-05	0.000269	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.000268	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL3—multiple sclerosis	3.03e-05	0.000264	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD40LG—multiple sclerosis	3.02e-05	0.000264	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2—multiple sclerosis	3.01e-05	0.000263	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—multiple sclerosis	2.98e-05	0.000261	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD4—multiple sclerosis	2.94e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTGER4—multiple sclerosis	2.91e-05	0.000255	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—multiple sclerosis	2.9e-05	0.000253	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-B—multiple sclerosis	2.87e-05	0.000251	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PGR—multiple sclerosis	2.87e-05	0.000251	CbGpPWpGaD
Trabectedin—SRC—Disease—CD86—multiple sclerosis	2.84e-05	0.000248	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD4—multiple sclerosis	2.82e-05	0.000247	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCR3—multiple sclerosis	2.81e-05	0.000246	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—IL6—multiple sclerosis	2.79e-05	0.000244	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD28—multiple sclerosis	2.79e-05	0.000244	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCR2—multiple sclerosis	2.74e-05	0.000239	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2RA—multiple sclerosis	2.69e-05	0.000235	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.67e-05	0.000233	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.67e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-A—multiple sclerosis	2.66e-05	0.000232	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.61e-05	0.000228	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—multiple sclerosis	2.58e-05	0.000225	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CNR1—multiple sclerosis	2.53e-05	0.000221	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—IL6—multiple sclerosis	2.52e-05	0.000221	CbGpPWpGaD
Trabectedin—SRC—Disease—CCR5—multiple sclerosis	2.52e-05	0.00022	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.51e-05	0.000219	CbGpPWpGaD
Trabectedin—SRC—Disease—HLA-A—multiple sclerosis	2.45e-05	0.000214	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.44e-05	0.000213	CbGpPWpGaD
Trabectedin—SRC—Immune System—TLR4—multiple sclerosis	2.43e-05	0.000212	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DRB1—multiple sclerosis	2.43e-05	0.000212	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—multiple sclerosis	2.39e-05	0.000209	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.38e-05	0.000208	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—multiple sclerosis	2.34e-05	0.000205	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MAPK1—multiple sclerosis	2.34e-05	0.000205	CbGpPWpGaD
Trabectedin—SRC—Immune System—ICAM1—multiple sclerosis	2.33e-05	0.000204	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MAPK1—multiple sclerosis	2.3e-05	0.000201	CbGpPWpGaD
Trabectedin—SRC—Disease—APOE—multiple sclerosis	2.29e-05	0.0002	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL10—multiple sclerosis	2.27e-05	0.000199	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD80—multiple sclerosis	2.24e-05	0.000196	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.24e-05	0.000196	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—multiple sclerosis	2.23e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Disease—CD80—multiple sclerosis	2.07e-05	0.000181	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK1—multiple sclerosis	2.07e-05	0.000181	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.05e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.05e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.02e-05	0.000177	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—APOE—multiple sclerosis	2.02e-05	0.000176	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD86—multiple sclerosis	1.99e-05	0.000174	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL5—multiple sclerosis	1.96e-05	0.000171	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.93e-05	0.000169	CbGpPWpGaD
Trabectedin—SRC—Immune System—TYK2—multiple sclerosis	1.89e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.87e-05	0.000163	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SPP1—multiple sclerosis	1.81e-05	0.000158	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—multiple sclerosis	1.8e-05	0.000157	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.78e-05	0.000155	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNG—multiple sclerosis	1.77e-05	0.000155	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCR5—multiple sclerosis	1.76e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000154	CbGpPWpGaD
Trabectedin—SRC—Disease—TYK2—multiple sclerosis	1.75e-05	0.000153	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2RA—multiple sclerosis	1.74e-05	0.000152	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—POMC—multiple sclerosis	1.73e-05	0.000151	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD4—multiple sclerosis	1.71e-05	0.00015	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APOE—multiple sclerosis	1.6e-05	0.00014	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—multiple sclerosis	1.59e-05	0.000139	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL1B—multiple sclerosis	1.58e-05	0.000138	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—multiple sclerosis	1.58e-05	0.000138	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—multiple sclerosis	1.58e-05	0.000138	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—multiple sclerosis	1.58e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000132	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD80—multiple sclerosis	1.45e-05	0.000127	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—POMC—multiple sclerosis	1.38e-05	0.00012	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL2—multiple sclerosis	1.35e-05	0.000118	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—multiple sclerosis	1.33e-05	0.000116	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000113	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TYK2—multiple sclerosis	1.22e-05	0.000107	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—multiple sclerosis	1.22e-05	0.000107	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK1—multiple sclerosis	1.21e-05	0.000105	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000103	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—APOE—multiple sclerosis	1.16e-05	0.000102	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000102	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—multiple sclerosis	1.14e-05	9.94e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—multiple sclerosis	1.14e-05	9.92e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK1—multiple sclerosis	1.11e-05	9.73e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.07e-05	9.35e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—APOE—multiple sclerosis	1.06e-05	9.27e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	8.9e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—POMC—multiple sclerosis	9.99e-06	8.73e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—multiple sclerosis	9.64e-06	8.43e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—multiple sclerosis	9.26e-06	8.09e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—POMC—multiple sclerosis	9.19e-06	8.03e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—POMC—multiple sclerosis	9.11e-06	7.96e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—multiple sclerosis	9.11e-06	7.96e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—multiple sclerosis	8.58e-06	7.49e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—multiple sclerosis	8.55e-06	7.47e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—multiple sclerosis	8.38e-06	7.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—multiple sclerosis	8.31e-06	7.26e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—multiple sclerosis	7.97e-06	6.96e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—multiple sclerosis	7.95e-06	6.94e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK1—multiple sclerosis	7.8e-06	6.81e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—APOE—multiple sclerosis	6.99e-06	6.11e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—POMC—multiple sclerosis	6.01e-06	5.25e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—multiple sclerosis	5.99e-06	5.23e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—multiple sclerosis	5.48e-06	4.79e-05	CbGpPWpGaD
